approval · primary record
EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC
FDA · BLA · 2026-05-08
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-08 |
| Brand | VYVGART HYTRULO |
| Sponsor | ARGENX BV |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:07.049Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC:2026-05-08
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.